跳至主要内容
临床试验/NCT01813760
NCT01813760已完成不适用

Treatment of Periorbital and Perioral Wrinkles With the Applications of the Iluminage Diode Laser

Cynosure, Inc.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Photographic Evaluation

研究概览

简要总结

The Diode laser system is being used in this marketing study for the treatment of wrinkles around the eyes and mouth.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects who are healthy females between 35 and 60 years of age.
  • Subjects who have Fitzpatrick skin type I-VI
  • Subjects who have provided written and verbal informed consent
  • Subjects who are willing and able to comply with study instructions and to return to the clinic for required visits and have photographs of their face taken
  • Subjects who have perioral and periorbital wrinkles, as deemed appropriate by the Investigator or his designees

排除标准

  • Subjects who currently use or have used in the prior 30 days any skin products that contain alpha hydroxy acids (AHA) e.g. glycolic, lactic, citric, or mendelic acid containing products or retinol/tretinoin containing products or exfoliating washes, masks or scrubs or other micro-dermabrasion skin care products. on the laser application areas
  • Subjects who are unwilling to maintain their daily skin care regimen for the duration of the study,
  • Subjects who have any skin pathology or condition that could interfere with the evaluation i.e. personal or family history of skin cancer, rosacea and/or requires the use of interfering topical or systemic therapies.
  • Subjects with synthetic or metal implants or permanent cosmetic tattoos in the test areas
  • Subjects who have a history of abnormal scarring, e.g. keloids or have significant scarring in the areas to be treated
  • Subjects with bleeding disorders or taking anticoagulation medications, including heavy use of aspirin
  • Subjects who have participated in any clinical investigation involving the face within the 30 days prior to the first planned laser application or subjects who plan to participate in concomitant facial studies during this trial
  • Subjects, who are pregnant, were pregnant or gave birth in the last 3 months, are currently breast feeding, or might become pregnant during the course of the study
  • Subjects who have a history of light triggered seizures
  • Subjects with prior use of neurotoxins e.g. Botox®, collagen, fat injections and/or other methods of skin augmentation (enhancement with injected or implanted material) of the face or having had chemical peels within 6 months of initial laser application or planning to so during the course of the study
  • Subject's use of oral isotretinoin (Accutane®) within 12 months of initial laser application or during the course of the study
  • Subjects having had facial skin treatments with any professional laser, light based, radiofrequency or other devices within the last year
  • Subjects ever having facial skin treatments with home use laser, light based or radiofrequency or other devices, i.e. PaloVia® or Tria®

结局指标

主要结局

Photographic Evaluation

时间窗: 60 days post first treatment

Compare severity of wrinkles from baseline to 60 days post treatment based on Fitpatrick Scale.

次要结局

  • Number of Participants with Adverse Events(up to 4 months post 1st treatment)
  • Photographic Evaluation(Up to 40 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验